|
| Home : MabVax Therapeutics Catches Eye of Billionaire Investor Dr. Phillip Frost and OPKO Health |
|
Apr 09
2015 |
MabVax Therapeutics Catches Eye of Billionaire Investor Dr. Phillip Frost and OPKO Health |
|
NEW YORK, NY--(Marketwired - April 08, 2015) - Investors at MabVax Therapeutics (OTCQB: MBVX) must feel like they're in just the right place at just the right time this week as news of billionaire Bio-Pharma Investor Dr. Phillip Frost, M.D., and his company OPKO Health (NYSE: OPK) have taken a strong interest in the clinical stage cancer immunotherapy company -- a $12 million interest. Dr. Frost is the CEO and Chairman of the Board at OPKO Health, and for those familiar with the good doctor, you already know that he and OPKO have a strong record of investing in biopharmaceutical firms. |
|
|
|
| Source:http://www.marketwired.com/mw/release.do?id=2007614&sourceType=3 |
| |
|
Related News
|
» Arcus Closes Private Placement With Existing Shareholders
» Verdict Reached in Boston Marathon Bombing Trial
|
|
|
